Home / Cancer
Cancer
| 3 min read
In a deal worth potentially just over a half billion dollars, SGX Pharmaceuticals is embarking on a license and collaboration agreement with Novartis that focuses on the development and commercialization of BCR-ABL inhibitors for the treatment of drug resistant chronic myelogenous leukemia (CML).
| 2 min read
Eli Lilly & Co. pilot study utilizes Optimata’s “virtual patient” technology to assist in the development of clinical trials for a novel anti-cancer cytotoxic compound.
| 3 min read
IBM, array-microscope technology developer DMetrix and BioImagene, recently announced that ultra-rapid whole-slide imaging and large-scale scientific image management have been integrated for first time.
| 2 min read
Illumina inks a nearly $7 million contract to conduct large-scale genotyping for United Kingdom-based research groups that are studying the molecular basis of prostate cancer.
| 3 min read
| 2 min read
At the same time it announced the signing of a research collaboration with Vancouver-based Inex Pharmaceuticals, RNAi specialist Alnylam announced a similar liposome research agreement with Dr. Robert Langer and colleagues at the Massachusetts Institute of Technology.
| 2 min read
Wyeth Pharmaceuticals and the Health Ministry of Scotland announced recently the creation of the Translational Medicine Research Collaboration (TMRC), an effort into which Wyeth is investing nearly $58.5 million.
| 3 min read
Biomedical imaging in playing an increasingly larger role in drug discovery. Ultrasonics, however, still brings to mind images of pregnant mothers and unborn babies. Toronto-based VisualSonics is hoping to change that impression. Recently, Executive Editor Randall C Willis spoke with VisualSonics President and CEO Tom Little.
